Published in Naunyn Schmiedebergs Arch Pharmacol on March 01, 1984
Interaction of amrinone with endogenous adenosine in guinea-pig atria. Br J Pharmacol (1986) 0.77
Complete remission of metastasised clear cell sarcoma of tendons and aponeuroses. Eur J Cancer (1991) 1.44
[The basics of catecholamine therapy. 2. A guide to clinical use]. Anasthesiol Intensivmed Notfallmed Schmerzther (2000) 1.43
Different sites of adenosine formation in the heart. Am J Physiol (1981) 1.39
Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J Biol Chem (1997) 1.30
Epicardial branches of the coronary arteries and their distribution in the rabbit heart: the rabbit heart as a model of regional ischemia. Anat Rec (1997) 1.20
Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart. Biochem J (1981) 1.14
Pelvic urine composition as a determinant of inner medullary solute concentration and urine osmolarity. Pflugers Arch (1972) 1.13
Aneurysm of the left sinus of Valsalva. An unusual source of cerebral embolism. Stroke (1996) 1.10
Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels. Eur J Pharmacol (1982) 1.09
Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors. Br J Pharmacol (1995) 1.09
Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. J Biol Chem (1992) 1.08
Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res (1987) 1.04
Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis. Circulation (1987) 1.03
Perioperative risk of bradyarrhythmias in patients with asymptomatic chronic bifascicular block or left bundle branch block: does an additional first-degree atrioventricular block make any difference? Anesthesiology (1998) 1.02
Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer (1999) 1.01
Adenosine receptor agonists: binding and adenylate cyclase stimulation in rat liver plasma membranes. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.00
Expression of two human beta-adrenergic receptors in Escherichia coli: functional interaction with two forms of the stimulatory G protein. Proc Natl Acad Sci U S A (1991) 0.98
Perioperative transcutaneous pacemaker in patients with chronic bifascicular block or left bundle branch block and additional first-degree atrioventricular block. Acta Anaesthesiol Scand (1999) 0.98
Coronary dilatory action of adenosine analogues: a comparative study. Arch Int Pharmacodyn Ther (1977) 0.96
The influence of obesity on perioperative morbidity: retrospective study of 502 aortocoronary bypass operations. Thorac Cardiovasc Surg (1992) 0.95
Effects of the bradycardic agent UL-FS 49 on exercise-induced regional contractile dysfunction in dogs. Int J Cardiol (1987) 0.95
The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.94
Interactions of the bovine brain A1-adenosine receptor with recombinant G protein alpha-subunits. Selectivity for rGi alpha-3. J Biol Chem (1991) 0.94
Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer--a retrospective analysis. Acta Med Austriaca (2001) 0.93
Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding. Biochem J (1991) 0.93
Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine. Circulation (1987) 0.93
Use of multi-plane transoesophageal echocardiography in visualization of the main hepatic veins and acquisition of Doppler sonography curves. Comparison with the transabdominal approach. Br J Anaesth (2001) 0.92
Effects of etomidate, midazolam, and thiopental on median nerve somatosensory evoked potentials and the additive effects of fentanyl and nitrous oxide. Anesth Analg (1988) 0.92
Differences in the GTP-regulation of membrane-bound and solubilized A1-adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.91
[Effect of Aminorex (Manocil) on hemodynamics of the pulmonary and systemic circulation during intravenous administration in dogs]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.90
Evidence against adenylate cyclase-coupled adenosine receptors in the guinea pig heart. Eur J Pharmacol (1981) 0.88
Enhancement of the coronary dilator effect of intravenous and intracoronary administered adenosine by hexobendine in dogs. Eur J Pharmacol (1971) 0.87
Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease. J Neurochem (1992) 0.87
NG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks. Drug Metab Dispos (1993) 0.87
Glomeruli and microvessels of the rabbit kidney contain both A1- and A2-adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.87
Assessment of changes in vasomotor tone in vivo using intravascular ultrasound. J Pharmacol Toxicol Methods (1992) 0.86
Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs. Br J Pharmacol (1988) 0.86
[Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents]. Arzneimittelforschung (1968) 0.86
P2-, but not P1-purinoceptors mediate formation of 1, 4, 5-inositol trisphosphate and its metabolites via a pertussis toxin-insensitive pathway in the rat renal cortex. Br J Pharmacol (1990) 0.86
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer. J Cancer Res Clin Oncol (1988) 0.86
The effects of adenosine on coronary conductance, cardiac dynamics and myocardial metabolism of the isolated perfused cat heart. Pharmacology (1974) 0.85
Experimental use of a modified fibrin glue to induce site-directed angiogenesis from the aorta to the heart. J Thorac Cardiovasc Surg (1994) 0.85
Can exercise-induced regional contractile dysfunction be prevented by selective bradycardic agents? Naunyn Schmiedebergs Arch Pharmacol (1986) 0.85
The effects of an intracoronary infusion of adenosine on cardiac performance, blood supply and on myocardial metabolism in dogs. Pflugers Arch (1970) 0.85
l-NG-nitro-arginine methyl ester in the anesthetized rabbit: venous vasomotion and plasma levels. J Vasc Res (1992) 0.84
Catecholamine excretion and heart rate as factors of psychophysical stress in table tennis. Int J Sports Med (1992) 0.84
The cyclin-dependent kinase inhibitor p21cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells. J Biol Chem (1997) 0.84
Effect of aminophylline on coronary reactive hyperaemia following brief and long occlusion periods. Cardiovasc Res (1977) 0.84
Effects of exercise on circulating vascular adhesion molecules in healthy men. Immunobiology (1997) 0.83
Evidence for glucagon-releasing activity of vasoactive adenosine analogues in the conscious dog. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.83
Cardiac ventricular beta 2-adrenoceptors in guinea-pigs and rats are localized on the coronary endothelium. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.83
A model of transient myocardial dysfunction in conscious dogs. Regional shortening in the presence of impaired coronary flow reserve and treadmill exercise. J Pharmacol Methods (1986) 0.83
The effects of NECA (adenosine-5'N-ethylcarboxamide) and of adenosine on glucagon and insulin release from the in situ isolated blood-perfused pancreas in anesthetized dogs. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.83
Characterization of angiotensin-II effects on cerebral and ocular circulation by noninvasive methods. Br J Clin Pharmacol (1997) 0.82
Role of nitric oxide in hemostatic system activation in vivo in humans. Arterioscler Thromb Vasc Biol (1995) 0.82
Phosphorylated adenosine derivatives as low-affinity adenosine-receptor agonists. Methodological implications for the adenylate cyclase assay. Biochem J (1984) 0.82
A different desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline. J Cardiovasc Pharmacol (1989) 0.82
Role of heart rate reduction in the treatment of exercise-induced myocardial ischaemia. Eur Heart J (1987) 0.82
The effects of intra-arterial adenosine infusion on substrate levels and blood flow in skeletal muscle of the dog. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.82
Usefulness of chromogranin A as a marker for detection of relapses of carcinoid tumours. Clin Chem Lab Med (1998) 0.82
2',3'-Dialdehyde GTP as an irreversible G protein antagonist. Disruption and reconstitution of G protein-mediated signal transduction in cells and cell membranes. J Biol Chem (1994) 0.81
Effects of alinidine on exercise-induced regional contractile dysfunction in dogs. Eur J Pharmacol (1986) 0.81
Effects of ischemia on the canine myocardial beta-adrenoceptor-linked adenylate cyclase system. J Cardiovasc Pharmacol (1987) 0.81
High-glucose incubation of human umbilical-vein endothelial cells does not alter expression and function either of G-protein alpha-subunits or of endothelial NO synthase. Biochem J (1996) 0.81
[Effect of hexobendine on the coronary efficacy of generalized hypoxia as well as of i.cor. and i.v. single injections of adenosine in dogs]. Arzneimittelforschung (1973) 0.81
Function of the autonomic nervous system in young, untreated hypertensive patients. Int J Cardiol (1986) 0.80
Effect of a 5'-substituted adenosine analogue (744c96) on insulin and glucagon release in isolated rat islets of Langerhans. Arch Int Pharmacodyn Ther (1979) 0.80
Antihypertensive effects of niguldipine-HCl (B 844-39), a new calcium antagonist in dogs. J Cardiovasc Pharmacol (1987) 0.80
Influence of aminophylline or beta-adrenoceptor blockade on glucagon release by a vasoactive adenosine analogue. Arch Int Pharmacodyn Ther (1978) 0.80
Effects of the acylcarnitine-transferase blocking agent sodium 2[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) on metabolism and regional function in the underperfused canine myocardium. J Cardiovasc Pharmacol (1985) 0.80
Mode of QT correction for heart rate: implications for the detection of inhomogeneous repolarization after myocardial infarction. Am Heart J (1992) 0.80
Fentanyl inhibits the canine carotid chemoreceptor reflex. Anesth Analg (1989) 0.80
Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level. Prostaglandins (1988) 0.80
Distribution and metabolism of NG-nitro-L-arginine and NG-nitro-L-arginine methylester in canine blood in vitro. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.80
Experimental exercise-induced ischemia: drug therapy can eliminate regional dysfunction and oxygen supply-demand imbalance. J Am Coll Cardiol (1986) 0.80
Growth of "new" coronary vascular structures by angiogenetic growth factors. Eur J Cardiothorac Surg (1993) 0.80
Immediate effects of mammary artery revascularization versus saphenous vein on global and regional myocardial function: an intraoperative echocardiographic assessment. Thorac Cardiovasc Surg (1991) 0.79
Propranolol ameliorates exercise-induced regional myocardial dysfunction in dogs. Clin Exp Pharmacol Physiol (1987) 0.79
[Memantine and neurogenic bladder disorders within the bounds of spastic conditions]. Arzneimittelforschung (1982) 0.79
Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo. Can J Physiol Pharmacol (1996) 0.79
Binding of [3H]ouabain to endothelial cells derived from various vascular beds. Basic Res Cardiol (1988) 0.79
Blockade of endothelium-derived relaxing factor synthesis with NG-nitro-L-arginine methyl ester leads to enhanced venous reactivity in vivo. Eur J Pharmacol (1992) 0.79
Pheochromocytoma of the urinary bladder--a case report and review of the literature. Urol Int (1984) 0.79
Alterations of the glomerular beta-adrenoceptor-linked adenylate cyclase system in perinephritis hypertension. J Cardiovasc Pharmacol (1986) 0.79
Age-related changes in vascular reactivity in genetically diabetic rats. Pharmacology (1995) 0.79
[Effects of morphine on the control of the cardiovascular system by the carotid-sinus-reflex and by the carotid chemoreflex]. Anaesthesist (1983) 0.79
The determination of the myocardial extracellular space in the cat in vivo: a comparative methodological study. Basic Res Cardiol (1976) 0.79
Esmolol: effects on isoprenaline- and exercise-induced cardiovascular stimulation in conscious dogs. Can J Physiol Pharmacol (1990) 0.79
The Erlanger Microlightguide Photometer: a new concept for monitoring intracapillary oxygen supply of tissue--first results and a review of the physiological basis. J Clin Monit (1996) 0.78
Myocardial effects of selective alpha-adrenoceptor blockade during exercise in dogs. Circ Res (1990) 0.78
Blood histamine levels and arteriovenous concentration differences after the intravenous administration of the basic compounds l-3 and 48/80 in the anaesthetized dog. Pharmacology (1975) 0.78
Bepridil abolishes exercise-induced regional contractile dysfunction in dogs. Int J Cardiol (1986) 0.78
Contractile responses to sympathetic activation after coronary instrumentation. Am J Physiol (1987) 0.78